NIH-funded research R01 grant

Using platelet markers and blood flow analysis to predict stroke recurrence in patients with narrowed arteries

Official title: Platelet Expression of FcgammaRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

Funded at University of California Los Angeles · NIH-11049115 · Data updated 2026-11-12

This study is looking at how certain markers in your blood and how blood flows in your arteries can help predict if you might have another stroke after experiencing a minor stroke or TIA, and it's for people who have recently had these types of strokes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2022
Project endMarch 31, 2027
Funding year2025
Award (this year)$633,985
NIH project number5R01NS123734-04
Project IDNIH-11049115 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced a minor stroke or TIA due to significant narrowing of the arteries in the brain.

Less likely to help

Patients who have not experienced a stroke or TIA, or those with other unrelated medical conditions, may not benefit from this research.

What this research studies

This research investigates how specific markers on platelets and the flow of blood in arteries can help predict the risk of recurrent strokes in patients who have experienced a minor stroke or transient ischemic attack (TIA) due to intracranial atherosclerosis. By analyzing patient-specific CT angiography and computational fluid dynamics, the study aims to develop a precision model that quantifies the risk of future ischemic events. The research will involve recruiting a diverse group of 250 participants who have recently suffered from acute cerebral ischemia, allowing for a comprehensive understanding of the factors contributing to stroke recurrence.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing recurrent strokes in at-risk patients.

How similar studies have gone: Previous research has shown promising results in using platelet markers and blood flow analysis to predict cardiovascular events, indicating that this approach may be effective.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Liebeskind, David Sigmund — University of California Los Angeles
  • Study coordinator: Liebeskind, David Sigmund

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.